| MeSH term | MeSH ID | Detail |
|---|---|---|
| Atherosclerosis | D050197 | 85 associated lipids |
| Diabetes Mellitus, Experimental | D003921 | 85 associated lipids |
| Arteriosclerosis | D001161 | 86 associated lipids |
| Diabetes Mellitus, Type 2 | D003924 | 87 associated lipids |
| Brain Ischemia | D002545 | 89 associated lipids |
| Diabetes Mellitus | D003920 | 90 associated lipids |
| Hypercholesterolemia | D006937 | 91 associated lipids |
| Insulin Resistance | D007333 | 99 associated lipids |
| Weight Gain | D015430 | 101 associated lipids |
| Glioma | D005910 | 112 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Bastos MF et al. | Hypertension may affect tooth-supporting alveolar bone quality: a study in rats. | 2010 | J. Periodontol. | pmid:20350157 |
| Ohkido I et al. | The hypothesis that bone turnover influences FGF23 secretion. | 2010 | Kidney Int. | pmid:20354552 |
| Dai M et al. | [Expression of receptor activator of nuclear factor kappaB ligand and osteoprotegerin of mice osteoblast induced by metal ions]. | 2010 | Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi | pmid:20369527 |
| Yu HC et al. | Mechanical stretching induces osteoprotegerin in differentiating C2C12 precursor cells through noncanonical Wnt pathways. | 2010 | J. Bone Miner. Res. | pmid:20200998 |
| Shan Y et al. | p38 MAPK plays a distinct role in sulforaphane-induced up-regulation of ARE-dependent enzymes and down-regulation of COX-2 in human bladder cancer cells. | 2010 | Oncol. Rep. | pmid:20204301 |
| Bao BY et al. | Clinical significance of tumor necrosis factor receptor superfamily member 11b polymorphism in prostate cancer. | 2010 | Ann. Surg. Oncol. | pmid:20204532 |
| Roshandel D et al. | Genetic variation in the RANKL/RANK/OPG signaling pathway is associated with bone turnover and bone mineral density in men. | 2010 | J. Bone Miner. Res. | pmid:20205168 |
| Grauslund J et al. | Does osteoprotegerin relate to micro- and macrovascular complications in long-term type 1 diabetes? | 2010 | Scand. J. Clin. Lab. Invest. | pmid:20205614 |
| Wang L et al. | Effects and mechanism of aromatic aminoketone SY0916 on osteoclastic bone destruction. | 2010 | Acta Pharmacol. Sin. | pmid:20208552 |
| Zagura M et al. | Association of osteoprotegerin with aortic stiffness in patients with symptomatic peripheral artery disease and in healthy subjects. | 2010 | Am. J. Hypertens. | pmid:20224558 |
| Lee JH et al. | Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal. | 2010 | Mol. Pharmacol. | pmid:19828731 |
| Kadoglou NP et al. | Aggressive lipid-lowering is more effective than moderate lipid-lowering treatment in carotid plaque stabilization. | 2010 | J. Vasc. Surg. | pmid:19837545 |
| Candido R et al. | Human full-length osteoprotegerin induces the proliferation of rodent vascular smooth muscle cells both in vitro and in vivo. | 2010 | J. Vasc. Res. | pmid:19907187 |
| Nabipour I et al. | Osteoprotegerin in relation to type 2 diabetes mellitus and the metabolic syndrome in postmenopausal women. | 2010 | Metab. Clin. Exp. | pmid:19922962 |
| Barbagallo I et al. | Overexpression of heme oxygenase-1 increases human osteoblast stem cell differentiation. | 2010 | J. Bone Miner. Metab. | pmid:19924377 |
| Takács I et al. | Allelic variations of RANKL/OPG signaling system are related to bone mineral density and in vivo gene expression. | 2010 | Eur. J. Endocrinol. | pmid:19934266 |
| Liu YY et al. | Circulating Dickkopf-1 and osteoprotegerin in patients with early and longstanding rheumatoid arthritis. | 2010 | Chin. Med. J. | pmid:20819596 |
| Eriksen CG et al. | The expression of IL-6 by osteoblasts is increased in healthy elderly individuals: stimulated proliferation and differentiation are unaffected by age. | 2010 | Calcif. Tissue Int. | pmid:20820764 |
| Camozzi V et al. | Persistent increase of osteoprotegerin levels after cortisol normalization in patients with Cushing's syndrome. | 2010 | Eur. J. Endocrinol. | pmid:19793762 |
| Bitto A et al. | Evidence for markers of hypoxia and apoptosis in explanted human carotid atherosclerotic plaques. | 2010 | J. Vasc. Surg. | pmid:20719466 |
| Caidahl K et al. | Osteoprotegerin: a biomarker with many faces. | 2010 | Arterioscler. Thromb. Vasc. Biol. | pmid:20720194 |
| Bergestuen DS et al. | Activin A in carcinoid heart disease: a possible role in diagnosis and pathogenesis. | 2010 | Neuroendocrinology | pmid:20720391 |
| Rutges JP et al. | Hypertrophic differentiation and calcification during intervertebral disc degeneration. | 2010 | Osteoarthr. Cartil. | pmid:20723612 |
| Pennisi P et al. | The association between carotid or femoral atherosclerosis and low bone mass in postmenopausal women referred for osteoporosis screening. Does osteoprotegerin play a role? | 2010 | Maturitas | pmid:20727694 |
| Nezami N et al. | Lovastatin raises serum osteoprotegerin level in people with type 2 diabetic nephropathy. | 2010 | Clin. Biochem. | pmid:20727867 |
| Zhang Y et al. | Osteogenic properties of hydrophilic and hydrophobic titanium surfaces evaluated with osteoblast-like cells (MG63) in coculture with human umbilical vein endothelial cells (HUVEC). | 2010 | Dent Mater | pmid:20728208 |
| Josson S et al. | Tumor-stroma co-evolution in prostate cancer progression and metastasis. | 2010 | Semin. Cell Dev. Biol. | pmid:19948237 |
| Luvizuto ER et al. | Histomorphometric analysis and immunolocalization of RANKL and OPG during the alveolar healing process in female ovariectomized rats treated with oestrogen or raloxifene. | 2010 | Arch. Oral Biol. | pmid:19948337 |
| Chollet ME et al. | Evidence of a colocalisation of osteoprotegerin (OPG) with von Willebrand factor (VWF) in platelets and megakaryocytes alpha granules. Studies from normal and grey platelets. | 2010 | Br. J. Haematol. | pmid:19958354 |
| Lossdörfer S et al. | Anabolic effect of intermittent PTH(1-34) on the local microenvironment during the late phase of periodontal repair in a rat model of tooth root resorption. | 2010 | Clin Oral Investig | pmid:19280233 |
| Cianciolo G et al. | Coronary calcifications in end-stage renal disease patients: a new link between osteoprotegerin, diabetes and body mass index? | 2010 | Blood Purif. | pmid:19816015 |
| Ozçaka O et al. | Plasma osteoprotegerin levels are decreased in smoker chronic periodontitis patients. | 2010 | Aust Dent J | pmid:21133939 |
| Taveira AT et al. | Longitudinal evaluation of hepatic osteodystrophy in children and adolescents with chronic cholestatic liver disease. | 2010 | Braz. J. Med. Biol. Res. | pmid:21049245 |
| Pivonka P et al. | Theoretical investigation of the role of the RANK-RANKL-OPG system in bone remodeling. | 2010 | J. Theor. Biol. | pmid:19782692 |
| Singh DK et al. | Low serum osteoprotegerin levels in normoalbuminuric type 1 diabetes mellitus. | 2010 | Acta Diabetol | pmid:19784545 |
| Han G et al. | Effects of simvastatin on relapse and remodeling of periodontal tissues after tooth movement in rats. | 2010 | Am J Orthod Dentofacial Orthop | pmid:21055594 |
| Jung CH et al. | The relationship between coronary artery calcification score, plasma osteoprotegerin level and arterial stiffness in asymptomatic type 2 DM. | 2010 | Acta Diabetol | pmid:19787288 |
| Ta HM et al. | Structure-based development of a receptor activator of nuclear factor-kappaB ligand (RANKL) inhibitor peptide and molecular basis for osteopetrosis. | 2010 | Proc. Natl. Acad. Sci. U.S.A. | pmid:21059944 |
| Pi M et al. | Impaired osteoblast function in GPRC6A null mice. | 2010 | J. Bone Miner. Res. | pmid:19874200 |
| Riches PL and Ralston SH | Recent insights into the biology of bone turnover. | 2010 | J R Coll Physicians Edinb | pmid:21125043 |
| Scheres N et al. | Gingival and periodontal ligament fibroblasts differ in their inflammatory response to viable Porphyromonas gingivalis. | 2010 | J. Periodont. Res. | pmid:19778323 |
| Oelzner P et al. | Combination therapy with dexamethasone and osteoprotegerin protects against arthritis-induced bone alterations in antigen-induced arthritis of the rat. | 2010 | Inflamm. Res. | pmid:20306217 |
| Jang JJ et al. | Elevated osteoprotegerin is associated with abnormal ankle brachial indices in patients infected with HIV: a cross-sectional study. | 2010 | J Int AIDS Soc | pmid:20307322 |
| Chadipiralla K et al. | Osteogenic differentiation of stem cells derived from human periodontal ligaments and pulp of human exfoliated deciduous teeth. | 2010 | Cell Tissue Res. | pmid:20309582 |
| Jørgensen L et al. | Bone loss in relation to serum levels of osteoprotegerin and nuclear factor-kappaB ligand: the Tromsø Study. | 2010 | Osteoporos Int | pmid:19701599 |
| Zhang Y et al. | Erythrina variegata extract exerts osteoprotective effects by suppression of the process of bone resorption. | 2010 | Br. J. Nutr. | pmid:20487580 |
| Sheng ZF et al. | OPG knockout mouse teeth display reduced alveolar bone mass and hypermineralization in enamel and dentin. | 2010 | Arch. Oral Biol. | pmid:20233613 |
| Castellino G et al. | The tumour necrosis factor-related apoptosis-inducing ligand-osteoprotegerin system in limited systemic sclerosis: a new disease marker? | 2010 | Rheumatology (Oxford) | pmid:20299382 |
| Son J et al. | cAMP-response-element-binding protein positively regulates breast cancer metastasis and subsequent bone destruction. | 2010 | Biochem. Biophys. Res. Commun. | pmid:20599715 |
| Horowitz MC et al. | How B cells influence bone biology in health and disease. | 2010 | Bone | pmid:20601290 |
| Nicolin V and Narducci P | Soluble TRAIL could enhance bone destruction acting on Rank-ligand in estrogen-independent human breast cancer cell line MDA-MB-231. | 2010 | Acta Histochem. | pmid:19058836 |
| Wasilewska A et al. | Serum RANKL, osteoprotegerin (OPG), and RANKL/OPG ratio in nephrotic children. | 2010 | Pediatr. Nephrol. | pmid:20602239 |
| Chang IC et al. | Platelet-rich fibrin modulates the expression of extracellular signal-regulated protein kinase and osteoprotegerin in human osteoblasts. | 2010 | J Biomed Mater Res A | pmid:20623670 |
| Molines L et al. | Charcot's foot: newest findings on its pathophysiology, diagnosis and treatment. | 2010 | Diabetes Metab. | pmid:20570543 |
| Giorgetti AP et al. | Cigarette smoke inhalation modulates gene expression in sites of bone healing: a study in rats. | 2010 | Oral Surg Oral Med Oral Pathol Oral Radiol Endod | pmid:20573527 |
| Nybo M et al. | Plasma osteoprotegerin concentrations in peripheral sensory neuropathy in Type 1 and Type 2 diabetic patients. | 2010 | Diabet. Med. | pmid:20536491 |
| Zhang F et al. | Compressive force stimulates the gene expression of IL-17s and their receptors in MC3T3-E1 cells. | 2010 | Connect. Tissue Res. | pmid:20497006 |
| Quercioli A et al. | Coronary artery calcification and cardiovascular risk: the role of RANKL/OPG signalling. | 2010 | Eur. J. Clin. Invest. | pmid:20497460 |
| Shaker OG et al. | Possible role of osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand as markers of plaque instability in coronary artery disease. | 2010 | Angiology | pmid:20498140 |
| Dai J et al. | Reversal of chemotherapy-induced leukopenia using granulocyte macrophage colony-stimulating factor promotes bone metastasis that can be blocked with osteoclast inhibitors. | 2010 | Cancer Res. | pmid:20501834 |
| Kerr NM et al. | Ocular manifestations of juvenile Paget disease. | 2010 | Arch. Ophthalmol. | pmid:20547946 |
| Liu JM et al. | Analysis of recently identified osteoporosis susceptibility genes in Han Chinese women. | 2010 | J. Clin. Endocrinol. Metab. | pmid:20554715 |
| Aoki S et al. | Function of OPG as a traffic regulator for RANKL is crucial for controlled osteoclastogenesis. | 2010 | J. Bone Miner. Res. | pmid:20560139 |
| Byron CR et al. | In vitro expression of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in cultured equine articular cells. | 2010 | Am. J. Vet. Res. | pmid:20513175 |
| Baekken M et al. | Osteoprotegrin and soluble tumor necrosis factor receptor 1 are associated with microalbuminuria in nontreated HIV-infected patients. | 2010 | J. Acquir. Immune Defic. Syndr. | pmid:20190590 |
| Tong PJ et al. | [In vitro induction studies of YouGui drink on culture of steroid induced necrosis of femoral head rat osteoblast]. | 2010 | Zhongguo Gu Shang | pmid:20191959 |
| Costa PP et al. | Salivary interleukin-6, matrix metalloproteinase-8, and osteoprotegerin in patients with periodontitis and diabetes. | 2010 | J. Periodontol. | pmid:20192865 |
| Leung R et al. | Diffuse osteosclerosis complicating hairy cell leukemia. | 2010 | J. Clin. Oncol. | pmid:20194859 |
| Takahashi N et al. | [Osteoprotegerin (OPG)]. | 2010 | Nippon Rinsho | pmid:20960766 |
| Wang EB et al. | [Histochemical and immunohistochemical double staining for osteolytic related factors in keratocystic odontogenic tumor]. | 2010 | Beijing Da Xue Xue Bao | pmid:20140051 |
| Schlieper G et al. | Analysis of calcifications in patients with coral reef aorta. | 2010 | Ann Vasc Surg | pmid:20144533 |
| Yan MZ et al. | Raloxifene inhibits bone loss and improves bone strength through an Opg-independent mechanism. | 2010 | Endocrine | pmid:20963556 |
| Ruckh TT et al. | Osteogenic differentiation of bone marrow stromal cells on poly(epsilon-caprolactone) nanofiber scaffolds. | 2010 | Acta Biomater | pmid:20144747 |
| Loncar G et al. | Relationship between RANKL and neuroendocrine activation in elderly males with heart failure. | 2010 | Endocrine | pmid:20963564 |
| Gibbons CL et al. | Osteoclast-like cells in soft tissue leiomyosarcomas. | 2010 | Virchows Arch. | pmid:20127110 |
| Enjuanes A et al. | The effect of the alendronate on OPG/RANKL system in differentiated primary human osteoblasts. | 2010 | Endocrine | pmid:20963568 |
| Mok SK et al. | Icariin protects against bone loss induced by oestrogen deficiency and activates oestrogen receptor-dependent osteoblastic functions in UMR 106 cells. | 2010 | Br. J. Pharmacol. | pmid:20128811 |
| Vik A et al. | Serum osteoprotegerin, sRANKL and carotid plaque formation and growth in a general population--the Tromsø study. | 2010 | J. Thromb. Haemost. | pmid:20128863 |
| Hughes C et al. | Human single-chain variable fragment that specifically targets arthritic cartilage. | 2010 | Arthritis Rheum. | pmid:20131274 |
| Fei Q et al. | Osteogenic growth peptide enhances the proliferation of bone marrow mesenchymal stem cells from osteoprotegerin-deficient mice by CDK2/cyclin A. | 2010 | Acta Biochim. Biophys. Sin. (Shanghai) | pmid:20926513 |
| Makihira S et al. | Immobilized-OPG-Fc on a titanium surface inhibits RANKL-dependent osteoclast differentiation in vitro. | 2010 | J Mater Sci Mater Med | pmid:19834789 |
| Reinhard H et al. | Osteoprotegerin and mortality in type 2 diabetic patients. | 2010 | Diabetes Care | pmid:20929997 |
| Tomlins C and Storey A | Cutaneous HPV5 E6 causes increased expression of Osteoprotegerin and Interleukin 6 which contribute to evasion of UV-induced apoptosis. | 2010 | Carcinogenesis | pmid:20884685 |
| Rachner TD et al. | Zoledronic acid induces apoptosis and changes the TRAIL/OPG ratio in breast cancer cells. | 2010 | Cancer Lett. | pmid:19577359 |
| Bai Y et al. | Formation of bone-like tissue by dental follicle cells co-cultured with dental papilla cells. | 2010 | Cell Tissue Res. | pmid:20886237 |
| Wutzl A et al. | Bone morphogenetic proteins 2, 5, and 6 in combination stimulate osteoblasts but not osteoclasts in vitro. | 2010 | J. Orthop. Res. | pmid:20872578 |
| Wang J and Stern PH | Osteoclastogenic activity and RANKL expression are inhibited in osteoblastic cells expressing constitutively active Gα(12) or constitutively active RhoA. | 2010 | J. Cell. Biochem. | pmid:20872746 |
| Ambrus C et al. | Bone mineral density in patients on maintenance dialysis. | 2010 | Int Urol Nephrol | pmid:20039127 |
| Jensen ED et al. | Bone morphogenic protein 2 directly enhances differentiation of murine osteoclast precursors. | 2010 | J. Cell. Biochem. | pmid:20039313 |
| Yamano E et al. | Inhibitory effects of orally administrated liposomal bovine lactoferrin on the LPS-induced osteoclastogenesis. | 2010 | Lab. Invest. | pmid:20421871 |
| Li XD et al. | Panax notoginseng saponins potentiate osteogenesis of bone marrow stromal cells by modulating gap junction intercellular communication activities. | 2010 | Cell. Physiol. Biochem. | pmid:21220939 |
| Marini H et al. | Efficacy of genistein aglycone on some cardiovascular risk factors and homocysteine levels: A follow-up study. | 2010 | Nutr Metab Cardiovasc Dis | pmid:19631515 |
| Trouvin AP and Goëb V | Receptor activator of nuclear factor-κB ligand and osteoprotegerin: maintaining the balance to prevent bone loss. | 2010 | Clin Interv Aging | pmid:21228900 |
| Tan YY et al. | Effects of vascular endothelial growth factor (VEGF) on MC3T3-E1. | 2010 | Orthod Craniofac Res | pmid:21040465 |
| Sun QF et al. | [Effects of high mobility group box 1 in activating periodontal ligament fibroblasts to express cytokine]. | 2010 | Hua Xi Kou Qiang Yi Xue Za Zhi | pmid:20848944 |
| Hesse E et al. | Zfp521 controls bone mass by HDAC3-dependent attenuation of Runx2 activity. | 2010 | J. Cell Biol. | pmid:21173110 |
| Tokuyama N and Tanaka S | [Cytokines in bone diseases. Genetic disorders of RANKL-RANK-OPG system]. | 2010 | Clin Calcium | pmid:20890036 |
| Hosogane N and Miyamoto T | [Cytokines in bone diseases. Osteoprotegerin and juvenile Paget's disease]. | 2010 | Clin Calcium | pmid:20890037 |
| Mesquita M et al. | Osteoprotegerin and progression of coronary and aortic calcifications in chronic kidney disease. | 2010 | Transplant. Proc. | pmid:21094794 |
| Zhou W et al. | [Effect of the compound of poly lactic-co-glycolic acid and bone marrow stromal cells modified by osteoprotegerin gene on the periodontal regeneration in Beagle dog periodontal defects]. | 2010 | Hua Xi Kou Qiang Yi Xue Za Zhi | pmid:20635668 |